Asset Allocation

As of February 28, 2026.
Type % Net
Cash 0.86%
Stock 78.59%
Bond 11.01%
Convertible 0.00%
Preferred 7.12%
Other 2.43%
View Asset Allocation
Start Trial

Market Capitalization

As of February 28, 2026
Large 94.41%
Mid 4.71%
Small 0.88%
View Market Capitalization
Start Trial

Region Exposure

% Developed Markets: 98.82%    % Emerging Markets: 0.06%    % Unidentified Markets: 1.11%

Americas 96.28%
94.39%
Canada 81.77%
United States 12.63%
1.89%
As of February 28, 2026. Region breakdown data is calculated by using the long position holdings of the portfolio.
Greater Europe 2.39%
United Kingdom 0.91%
1.48%
Denmark 0.00%
France 0.05%
Germany 0.53%
Ireland 0.86%
Netherlands 0.00%
Spain 0.03%
Switzerland 0.00%
0.00%
0.00%
Greater Asia 0.22%
Japan 0.00%
0.21%
Australia 0.21%
0.00%
Singapore 0.00%
0.00%
Unidentified Region 1.11%

Bond Credit Quality Exposure

AAA 32.12%
AA 8.05%
A 17.01%
BBB 20.05%
BB 6.39%
B 1.71%
Below B 0.15%
    CCC 0.15%
    CC 0.00%
    C 0.00%
    DDD 0.00%
    DD 0.00%
    D 0.00%
Not Rated 0.23%
Not Available 14.28%
Short Term 0.00%
As of February 28, 2026
View Bond Credit Quality Exposure
Start Trial

Stock Sector Exposure

Cyclical
60.50%
Materials
1.58%
Consumer Discretionary
5.13%
Financials
53.78%
Real Estate
0.00%
Sensitive
30.73%
Communication Services
1.09%
Energy
10.82%
Industrials
15.18%
Information Technology
3.63%
Defensive
8.41%
Consumer Staples
2.65%
Health Care
2.26%
Utilities
3.49%
Not Classified
0.37%
Non Classified Equity
0.24%
Not Classified - Non Equity
0.13%
As of February 28, 2026
View Region Exposure
Start Trial

Bond Sector Exposure

As of February 28, 2026
Type % Net
Government 31.18%
Corporate 45.13%
Securitized 0.36%
Municipal 13.04%
Other 10.29%
View Bond Sector Exposure
Start Trial

Bond Maturity Exposure

Short Term
1.60%
Less than 1 Year
1.60%
Intermediate
62.69%
1 to 3 Years
5.72%
3 to 5 Years
14.42%
5 to 10 Years
42.55%
Long Term
33.55%
10 to 20 Years
9.90%
20 to 30 Years
14.23%
Over 30 Years
9.42%
Other
2.16%
As of February 28, 2026
View Bond Maturity Exposure
Start Trial